PISCATAWAY, N,J.– Camber has added Voriconazole for Injection [vor-i-KON-a-zole] to its expanding portfolio.
Voriconazole for Injection is indicated for a variety of fungal infections in adult and pediatric patients (2 years of age and older) including:
- Invasive Aspergillosis
- Candidemia in Non-neutropenic Patients and Other Deep Tissue Candida Infections
- Esophageal Candidiasis and in patient's intolerant of, or refractory to other therapy,
- Scedosporiosis
- Fusariosis
For complete indications, please click here.
Voriconazole for Injection is available in 200 mg Single-Dose Vials.
For more information, visit: www.camberpharma.com/voriconazole
